JASPER THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -44.1% | -44.1% | -32.7% |
| FY2022 | -104.7% | -104.7% | -77.9% |
| FY2023 | -82.2% | -82.2% | -67.9% |
| FY2024 | -115.6% | -115.6% | -89.2% |
| FY2025 | -1,826.1% | -1,826.1% | -211.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -44.1% | -44.1% | -32.7% |
| FY2022 | -104.7% | -104.7% | -77.9% |
| FY2023 | -82.2% | -82.2% | -67.9% |
| FY2024 | -115.6% | -115.6% | -89.2% |
| FY2025 | -1,826.1% | -1,826.1% | -211.9% |